U0126, a mitogen-activated protein kinase kinase inhibitor, inhibits the invasion of human A375 melanoma cells

Cancer Letters

Volumn 179, Issue 2, 2002, Pages 133-140

  Ge, Xiaokang ^a   Fu, Ya Min ^a   Meadows, Gary G ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Invasion; MEK inhibitors; Melanoma; Metalloproteinases; Urokinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN C JUN; UO 126; UROKINASE;

ARTICLE; CANCER INVASION; CELL LINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; ONCOGENE C FOS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME;

BUTADIENES; ENZYME INHIBITORS; FLAVONOIDS; HUMANS; MATRIX METALLOPROTEINASE 9; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; NITRILES; PHOSPHORYLATION; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0037188432     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00004-6     Document Type: Article

References (41)

1. Deregulation of the signaling pathways controlling urokinase production: Its relationship with the invasive phenotype
2. Urokinase-type plasminogen activator: Proenzyme, receptors and inhibitors
3. Cell-associated plasminogen activation: Regulation and physiological functions
4. Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells
5. Cytoskeleton reorganization induces the urokinase-type plasminogen activator gene via the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway
6. Differential regulation of urokinase-type plasminogen activator expression by basic fibroblast growth factor and serum in myogenesis
7. Pulmonary epithelial cell urokinase-type plasminogen activator: Induction by interleukin-1 beta and tumor necrosis factor
8. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
9. A regulatory element that mediates co-operation between a PEA3-AP-1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells
10. Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-α via α5β1 integrin in HL-60 cells
11. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: Involvement of Ras-dependent and -independent pathways
12. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and GT box homologous to retinoblastoma control elements: A mechanism regulating gene expression independent of that by inflammatory cytokines
13. Differential modulation of plasminogen activator gene expression by oncogene-encoded protein tyrosine kinases
14. Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes
15. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences
16. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes
17. UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: Requirement of an AP1 enhancer element
18. r 92 000 type IV collagenase secretion and in vitro invasion
19. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment
20. Decreased tissue plasminogen activator and increased plasminogen activator inhibitors and increased activator protein-1 and specific promoter 1 are associated with inhibition of invasion in human A375 melanoma deprived of tyrosine and phenylalanine
21. Biology and biochemistry of proteinases in tumor invasion
22. The urokinase-type plasminogen activator system in cancer metastasis: A review
23. Regulation of the uPA gene in various grades of human glioma cells
24. Signal transduction and uPA/uPA system
25. Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras
26. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor
27. Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
28. Involvement of the Ras/MAPK signaling pathway in the modulation of urokinase production and cellular invasiveness by transforming growth factor-β1 in transformed keratinocytes
29. Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion
30. Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38α mitogen-activated protein kinase activity
31. 'Proteolytic switching': Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
32. Regulatory mechanisms of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells
33. Invasion and metastasis
34. Amplification of IL-1 β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-κB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways
35. Tumor cell contact mediated transcription activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat
36. Regulation of 92 kDa type IV collagenase expression by the Jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades
37. Effect of PD98059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion
38. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades
39. ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtained high urokinase expression and rapid cell proliferation
40. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
41. Expression of urokinase-type plasminogen activator (uPA), uPA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma